UBS Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $25

10/12/2026
Impact: 75
Healthcare

UBS analyst Alice Nettleton has initiated coverage on Kardigan (NASDAQ: KARD) with a Buy rating. The firm has set a price target of $25 for the stock.

AI summary, not financial advice

Share: